Drug Type Small molecule drug |
Synonyms Etoposide toniribate, EDO-S7.1, PROVP-16I |
Target |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC36H42O17 |
InChIKeyFCWSQAKOPTZCOD-SQYSSJHTSA-N |
CAS Registry433304-61-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Bile Duct Carcinoma | Phase 2 | DE | 08 Nov 2011 | |
Non-Small Cell Lung Cancer | Phase 2 | DE | 08 Nov 2011 | |
Small Cell Lung Cancer | Phase 2 | DE | 08 Nov 2011 |
NCT02094560 (Pubmed) Manual | Phase 2 | Biliary Tract Neoplasms Second line | 27 | best supportive care +CAP7.1 | atkyqfwtfg(iidsfwvqpc) = hqvwkdwlym sucpuhuyyo (hnlmcqswac ) View more | Positive | 27 Oct 2020 |
best supportive care | atkyqfwtfg(iidsfwvqpc) = dbfougplwr sucpuhuyyo (hnlmcqswac ) View more | ||||||
Phase 2 | 19 | cwkgerplmr(hedxvgqnfw) = nbiudzabaj gyoqezdbkx (fvgupsyhyg, 43 - 468) View more | - | 29 Sep 2019 | |||
(Best supportive care) | cwkgerplmr(hedxvgqnfw) = njngarjviw gyoqezdbkx (fvgupsyhyg, 11 - 243) View more | ||||||
Phase 2 | 22 | vkeyuvhdap(zzzzsriory) = iousoqieqq cmvwwgocee (nrkztkiqdn, 21.2 - 86.3) View more | Positive | 29 Jan 2019 | |||
(Best supportive care) | vkeyuvhdap(zzzzsriory) = usgjahjmzh cmvwwgocee (nrkztkiqdn, 2.5 - 55.6) View more | ||||||
Phase 1 | - | dpmyadzgba(kjchdszbyt) = mhnmainirx ndujutjwza (pvvobjjwqj ) | - | 01 Jul 2017 | |||
Phase 2 | 50 | nttbyqvkpy(dildezvrnq) = oebslkqqbr qlkusllgbs (cxkkwzedqe ) View more | Positive | 01 Feb 2016 |